Review suitability before discussing stem-cell treatment.
MSC therapy is handled within the Category II regenerative-medicine framework. The first step is not a treatment booking. It is a physician review of images, symptoms, medical history, medications, cancer history, cell-processing quality, costs, and risks.
Ask about MSC consultationTwo MSC consultation lanes are shown with plan numbers.
Intravenous infusion may be included.
MSC consultation for chronic pain. The physician reviews whether an MSC option is appropriate after records, testing, consent, and quality confirmation.
Plan numbers: PB3240161 / PB3250154.
Intra-articular administration may be included.
MSC consultation for osteoarthritis. MRI findings, symptoms, previous treatments, and risk factors are reviewed before any next step.
Plan numbers: PB3240166 / PB3250155.
Filed / notified provision-plan information describes the provider framework under Japan's Act on Safety of Regenerative Medicine. It is not a national efficacy endorsement and does not promise outcomes.
Testing and records
Bring imaging, blood tests, medication history, previous treatment history, and current symptoms.
Physician review
The physician reviews suitability, risks, alternatives, and whether referral or follow-up is more appropriate.
Consent and quality
If an MSC path is considered, cost, main risks, consent, cell-processing steps, and quality confirmation are explained.
Public registry and official channels.
These links point to Japan's public registry pages for filed regenerative-medicine provision plans and to the clinic's official YouTube / Instagram channels. Registry publication is a reference for filed provision-plan information; it is not evidence of individual treatment outcomes or absence of risk.